Acute Hepatic Porphyria (AHP)
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to AHP.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Congresses
Acute Hepatic Porphyria (AHP)
American Association for the Study of Liver Diseases (AASLD) 2024
Acute Hepatic Porphyria (AHP)
International Congress of Porphyrins and Porphyrias (ICPP) 2024
Publications
Acute Hepatic Porphyria (AHP)
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial
Journal of Hepatology
Acute Hepatic Porphyria (AHP)
Pharmacokinetic-Pharmacodynamic Model of Urinary δ-Aminolevulinic Acid Reduction After Givosiran Treatment in Patients with Acute Hepatic Porphyria
CPT: Pharmacometrics & Systems Pharmacology
Acute Hepatic Porphyria (AHP)
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria
Clinical Pharmacokinetics
Acute Hepatic Porphyria (AHP)
EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms
Journal of Inherited Metabolic Disease
Acute Hepatic Porphyria (AHP)
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran
Expert Review of Gastroenterology & Hepatology
